retatrutide phase 2 results obesity nejm 2023 π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending Phase 2 Trial of Retatrutide
Description
Some hair loss specialists recommend 1.2 to 1.5 grams per kilogram during active weight loss on GLP-1 medications

The upper outer arm over the triceps area is the approved injection site, though most manufacturers recommend having another person administer arm injections due to accessibility challenges

Human islets were maintained in culture for up to 48 h in RPMI medium containing 10% (vol./vol.) FCS, 1% (vol./vol.) penicillin/streptomycin and 5 mmol/l glucose
Still, we recommend talking to a healthcare professional before changing or stopping any prescribed medication

This pricing applies across all three commitment tiers and includes medications from licensed 503A compounding pharmacies
